<DOC>
	<DOCNO>NCT01994187</DOCNO>
	<brief_summary>Investigate current situation carotid stenosis therapy China . Establish data bank carotid stenosis revascularization ( CAS CEA ) China , order get best quality control therapy , well confirm standard treatment carotid stenosis . Understand situation adverse event occur revascularization ( CAS CEA ) , evaluate health economics .</brief_summary>
	<brief_title>Revascularization Extracranial Carotid Artery Stenosis</brief_title>
	<detailed_description>The carotid stenosis one high risk ischemia stroke China.In mean time , people accept revascularization carotid stenosis.NASCAT indicate CEA `` golden standard '' therapy carotid stenosis.But china , case opposite , little patient receive CEA , hand , patient receive angioplasty . Expected less 2100 case within 2 year whole study . We choose 39 hospital whose experienced CAS or/and CEA spread country multiple center clinic registration study . All case inclusion must continuously registration . The subject choice : All register patient must sign informed consent register non intrusive research study , researcher study period continuous registration patient undergoing surgical treatment carotid stenosis , ensure select participant reflect target patient population . Medical Center choice : This research study registration , therefore , choice , medical center base market research data . Primary endpoint main aim registration study observe follow detail : 1 . The participant suffer stroke ( ischemic hemorrhagic ) , death cardiovascular event within 30 day revascularization procedure . 2 . The participant suffer ipsilateral stroke ( ischemic hemorrhagic ) death beyond 30 day 12 month revascularization procedure . Secondary endpoint aim registration study : 1 . Success rate procedure ( CAS CEA ) . 2. postoperative complication , include hyperperfusion syndrome , TIA , ipsilateral infarction , vascular dissection adverse event . 3 . To observe rate restenosis follow-up . 4 . Stroke patient TIA mainly heart attack cardiovascular event follow-up . 5 . Changes patient mRS NIHSS Barthel Index score . 6 . Postoperative patient drug use . 7 . Patient survival 12 month . 8 . Patients hospitalize cost follow-up . This study need random . The study expect begin July 2013 first , participant group stage two year , end June 2015 group patient surgery , follow-up least 12 month last case participant group follow 12 month , expect complete June 2015 .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Carotid Stenosis</mesh_term>
	<criteria>consecutive case carotid stenosis receive CEA or/and CAS central hospital study ( upto 2015 ) . case carotid stenosis receive CEA or/and CAS hospital ( enroll study ) exclusion .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Carotid stenosis</keyword>
	<keyword>Angioplasty</keyword>
	<keyword>Carotid endarterectomy</keyword>
	<keyword>Stroke</keyword>
</DOC>